Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759

References

• Ling L, Tan Z, Zhang C, et al. Long noncoding RNA ENSRNOG00000037522 is involved in the podocyte epithelial‑mesenchymal transition in diabetic rats. Int J Mol Med. 2018;41:2704–2714.
   PubMed Web of Science ®Google Scholar
• Dai H, Liu Q, Liu B. Research progress on mechanism of podocyte depletion in diabetic nephropathy. J Diabetes Res. 2017;2017:2615286.
   PubMed Web of Science ®Google Scholar
• Loeffler I, Wolf G. Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction? Cells. 2015;4:631–652.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Iwano M, Suzuki D, et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis. 2009;54:653–664.
   PubMed Web of Science ®Google Scholar
• Wang X, Xu Y, Zhu YC, et al. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy. J Cell Physiol. 2019;234:12926–12933.
   Web of Science ®Google Scholar
• Gao J, Wang W, Wang F, et al. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy. Biomed Pharmacothe. 2018;106:543–552.
   PubMed Web of Science ®Google Scholar
• Chen YN, Wu CG, Shi BM, et al. The protective effect of asiatic acid on podocytes in the kidney of diabetic rats. Am J Transl Res. 2018;10:3733–3741.
   PubMed Web of Science ®Google Scholar
• Alqahtani A, Hamid K, Kam A, et al. The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Curr Med Chem. 2013;20:908–931.
   PubMed Web of Science ®Google Scholar
• Liao H, Hu L, Cheng X, et al. Are the therapeutic effects of huangqi (Astragalus membranaceus) on diabetic nephropathy correlated with its regulation of macrophage iNOS activity? J Immunol Res. 2017;2017:3780572.
   PubMed Web of Science ®Google Scholar
• Kim J, Moon E, Kwon S. Effect of Astragalus membranaceus extract on diabetic nephropathy. Endocrinol Diabetes Metab Case Rep. 2014;2014:140063.
   PubMedGoogle Scholar
• Wang Z, Sun WS, Liu JT. Impacts of asiaticoside on cytoskeleton and p38 pathway in podocytes (in Chinese). World J Integr Tradit West Med. 2015;10:1456–1459.
   Google Scholar
• Ramesh BN, Girish TK, Raghavendra RH, et al. Comparative study on anti-oxidant and anti-inflammatory activities of Caesalpinia crista and Centella asiatica leaf extracts. J Pharm Bioallied Sci. 2014;6:86–91.
   PubMedGoogle Scholar
• Zhai R, Jian G, Chen T, et al. Astragalus membranaceus and Panax notoginseng, the novel renoprotective compound, synergistically protect against podocyte injury in streptozotocin-induced diabetic rats. J Diabetes Res. 2019;2019:1602892.
   PubMed Web of Science ®Google Scholar
• Hu CM, Li JS, Cheah KP, et al. Effect of Sanguis draconis (a dragon’s blood resin) on streptozotocin- and cytokine-induced beta-cell damage, in vitro and in vivo. Diabetes Res Clin Pract. 2011;94:417–425.
   PubMed Web of Science ®Google Scholar
• Li Y, Ren D, Xu G. Long noncoding RNA MALAT1 mediates high glucose-induced glomerular endothelial cell injury by epigenetically inhibiting klotho via methyltransferase G9a. IUBMB Life. 2019;71:873–881.
   Web of Science ®Google Scholar
• Shen H, Ming Y, Xu C, et al. Deregulation of long noncoding RNA (TUG1) contributes to excessive podocytes apoptosis by activating endoplasmic reticulum stress in the development of diabetic nephropathy. J Cell Physiol. 2019;234:15123–15133.
   Web of Science ®Google Scholar
• Lu H, Chen B, Hong W, et al. Transforming growth factor-beta1 stimulates hedgehog signaling to promote epithelial-mesenchymal transition after kidney injury. Febs J. 2016;283:3771–3790.
   PubMed Web of Science ®Google Scholar
• Lu X, Li M, Zhou L, et al. Urinary serum- and glucocorticoid-inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy. Nephrology (Carlton, Vic). 2014;19:307–317.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X, Wang Y, et al. SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT. J Exp Clin Cancer Res. 2018;37:73.
   PubMed Web of Science ®Google Scholar
• Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010;31:68–74.
   PubMed Web of Science ®Google Scholar
• Sun Z, Ma Y, Chen F, et al. miR-133b and miR-199b knockdown attenuate TGF-beta1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy. Eur J Pharmacol. 2018;837:96–104.
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang Q, Wang Y, et al. SGK1-mediated fibronectin formation in diabetic nephropathy. Cell Physiol Biochem. 2005;16:237–244.
   PubMed Web of Science ®Google Scholar
• Cheng J, Truong LD, Wu X, et al. Serum- and glucocorticoid-regulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition. Kidney Int. 2010;78:668–678.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yin Z, Li H, et al. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice. Aging Cell. 2017;16:387–400.
   PubMed Web of Science ®Google Scholar
• Yue Y, Meng K, Pu Y, et al. Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract. 2017;133:124–130.
   PubMed Web of Science ®Google Scholar
• Loeffler I. MKP2 suppresses TGF-beta1-induced epithelial-to-mesenchymal transition through JNK inhibition. Clin Sci. 2019;133:545–550.
   PubMed Web of Science ®Google Scholar
• Kim J-H, Ham S, Lee Y, et al. TTC3 contributes to TGF-β(1)-induced epithelial-mesenchymal transition and myofibroblast differentiation, potentially through SMURF2 ubiquitylation and degradation. Cell Death Dis. 2019;10:92.
   PubMed Web of Science ®Google Scholar
• Lu Q, Wang WW, Zhang MZ, et al. ROS induces epithelial-mesenchymal transition via the TGF-beta1/PI3K/Akt/mTOR pathway in diabetic nephropathy. Exp Ther Med. 2019;17:835–846.
   PubMed Web of Science ®Google Scholar
• Lang F, Bohmer C, Palmada M, et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev. 2006;86:1151–1178.
   PubMed Web of Science ®Google Scholar
• Steinberger M, Foller M, Vogelgesang S, et al. Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle. Pflugers Arch. 2015;467:1965–1974.
   PubMed Web of Science ®Google Scholar